These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 38568394)
1. Type 1 fimbrial phase variation in multidrug-resistant asymptomatic uropathogenic Escherichia coli clinical isolates upon adherence to HTB-4 cells. Ghosh A; Mukherjee M Folia Microbiol (Praha); 2024 Dec; 69(6):1185-1204. PubMed ID: 38568394 [TBL] [Abstract][Full Text] [Related]
2. Incidence of multidrug resistance, pathogenicity island markers, and pathoadaptive FimH mutations in uropathogenic Escherichia coli isolated from asymptomatic hospitalized patients. Ghosh A; Mukherjee M Folia Microbiol (Praha); 2019 Jul; 64(4):587-600. PubMed ID: 30835050 [TBL] [Abstract][Full Text] [Related]
3. Uropathogenic Escherichia coli in India-an Overview on Recent Research Advancements and Trends. Ghosh A; Bandyopadhyay D; Koley S; Mukherjee M Appl Biochem Biotechnol; 2021 Jul; 193(7):2267-2296. PubMed ID: 33595784 [TBL] [Abstract][Full Text] [Related]
4. Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae. Spurbeck RR; Stapleton AE; Johnson JR; Walk ST; Hooton TM; Mobley HL Infect Immun; 2011 Dec; 79(12):4753-63. PubMed ID: 21911462 [TBL] [Abstract][Full Text] [Related]
5. Molecular Analysis of Abdul Raheem Hasan S; Sajid Al-Jubori S; Abdul Sattar Salman J Arch Razi Inst; 2021 Oct; 76(4):829-840. PubMed ID: 35096318 [TBL] [Abstract][Full Text] [Related]
6. Distribution of chaperone-usher fimbriae and curli fimbriae among uropathogenic Escherichia coli. Golpasand T; Keshvari M; Behzadi P BMC Microbiol; 2024 Sep; 24(1):344. PubMed ID: 39271999 [TBL] [Abstract][Full Text] [Related]
7. Epidemiologic and molecular characterization of β-lactamase-producing multidrug-resistant uropathogenic Escherichia coli isolated from asymptomatic hospitalized patients. Ghosh A; Ghosh B; Mukherjee M Int Microbiol; 2022 Jan; 25(1):27-45. PubMed ID: 34191193 [TBL] [Abstract][Full Text] [Related]
8. In Vivo Consumption of Cranberry Exerts ex Vivo Antiadhesive Activity against FimH-Dominated Uropathogenic Escherichia coli: A Combined in Vivo, ex Vivo, and in Vitro Study of an Extract from Vaccinium macrocarpon. Rafsanjany N; Senker J; Brandt S; Dobrindt U; Hensel A J Agric Food Chem; 2015 Oct; 63(40):8804-18. PubMed ID: 26330108 [TBL] [Abstract][Full Text] [Related]
9. Altered Regulation of the Diguanylate Cyclase YaiC Reduces Production of Type 1 Fimbriae in a Pst Mutant of Uropathogenic Escherichia coli CFT073. Crépin S; Porcheron G; Houle S; Harel J; Dozois CM J Bacteriol; 2017 Dec; 199(24):. PubMed ID: 28924030 [TBL] [Abstract][Full Text] [Related]
11. Regulation of type 1 fimbriae by unlinked FimB- and FimE-like recombinases in uropathogenic Escherichia coli strain CFT073. Bryan A; Roesch P; Davis L; Moritz R; Pellett S; Welch RA Infect Immun; 2006 Feb; 74(2):1072-83. PubMed ID: 16428754 [TBL] [Abstract][Full Text] [Related]
12. The affinity of the FimH fimbrial adhesin is receptor-driven and quasi-independent of Escherichia coli pathotypes. Bouckaert J; Mackenzie J; de Paz JL; Chipwaza B; Choudhury D; Zavialov A; Mannerstedt K; Anderson J; Piérard D; Wyns L; Seeberger PH; Oscarson S; De Greve H; Knight SD Mol Microbiol; 2006 Sep; 61(6):1556-68. PubMed ID: 16930149 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of type 1 fimbriae regulation in fimB-null strains from the multidrug resistant Escherichia coli ST131 clone. Sarkar S; Roberts LW; Phan MD; Tan L; Lo AW; Peters KM; Paterson DL; Upton M; Ulett GC; Beatson SA; Totsika M; Schembri MA Mol Microbiol; 2016 Sep; 101(6):1069-87. PubMed ID: 27309594 [TBL] [Abstract][Full Text] [Related]
14. Decreased expression of type 1 fimbriae by a pst mutant of uropathogenic Escherichia coli reduces urinary tract infection. Crépin S; Houle S; Charbonneau MÈ; Mourez M; Harel J; Dozois CM Infect Immun; 2012 Aug; 80(8):2802-15. PubMed ID: 22665376 [TBL] [Abstract][Full Text] [Related]
15. Genotypic and phenotypic characterisation of asymptomatic bacteriuria (ABU) isolates displaying bacterial interference against multi-drug resistant uropathogenic E. Coli. Kenneally C; Murphy CP; Sleator RD; Culligan EP Arch Microbiol; 2024 Sep; 206(10):394. PubMed ID: 39245770 [TBL] [Abstract][Full Text] [Related]
16. Antiadhesive natural products against uropathogenic E. coli: What can we learn from cranberry extract? Scharf B; Schmidt TJ; Rabbani S; Stork C; Dobrindt U; Sendker J; Ernst B; Hensel A J Ethnopharmacol; 2020 Jul; 257():112889. PubMed ID: 32311481 [TBL] [Abstract][Full Text] [Related]
17. Virulence factors of uropathogenic Escherichia coli of urinary tract infections and asymptomatic bacteriuria in children. Yun KW; Kim HY; Park HK; Kim W; Lim IS J Microbiol Immunol Infect; 2014 Dec; 47(6):455-61. PubMed ID: 24064288 [TBL] [Abstract][Full Text] [Related]
18. Virulence properties of Escherichia coli 83972, a prototype strain associated with asymptomatic bacteriuria. Hull RA; Rudy DC; Donovan WH; Wieser IE; Stewart C; Darouiche RO Infect Immun; 1999 Jan; 67(1):429-32. PubMed ID: 9864249 [TBL] [Abstract][Full Text] [Related]
19. Identification and Characterization of a Phase-Variable Element That Regulates the Autotransporter UpaE in Uropathogenic Escherichia coli. Battaglioli EJ; Goh KGK; Atruktsang TS; Schwartz K; Schembri MA; Welch RA mBio; 2018 Aug; 9(4):. PubMed ID: 30087170 [TBL] [Abstract][Full Text] [Related]
20. Regulation of type 1 fimbriae synthesis and biofilm formation by the transcriptional regulator LrhA of Escherichia coli. Blumer C; Kleefeld A; Lehnen D; Heintz M; Dobrindt U; Nagy G; Michaelis K; Emödy L; Polen T; Rachel R; Wendisch VF; Unden G Microbiology (Reading); 2005 Oct; 151(Pt 10):3287-3298. PubMed ID: 16207912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]